The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.80
Ask: 48.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.418%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.00
VSL Live PriceLast checked at -
VPC Specialty Lending Investments is an Investment Trust

To generate an attractive total return for shareholders consisting of dividend income and capital growth through investments in specialty lending opportunities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Responsibilities and Director Appointment

26 Apr 2019 07:02

RNS Number : 1660X
VPC Specialty Lending Invest. PLC
26 April 2019
 

26 April 2019

VPC Specialty Lending Investments PLC (the "Company")

Director Responsibilities and Appointment of Non-Executive Director

 

The Board is pleased to announce the appointment of existing independent non-executive directors Kevin Ingram as Chairman of the Company, and Clive Peggram as Chairman of the Audit & Valuation Committee, effective immediately. Further, the Board is pleased to announce the appointment of Mark Katzenellenbogen as a new independent non-executive director with effect from 1 May 2019

 

On 14 December 2018, the Company previously announced that Kevin Ingram would step in for Andrew Adcock as interim Chairman of the Board and Clive Peggram would stand in for Kevin Ingram as interim Chairman of the Audit and Valuation Committee. Following the passing away of the previous Chairman, Andrew Adcock, in January of this year and after reviewing the performance of both Kevin Ingram and Clive Peggram in the interim period, the Board was pleased to approve the recommendation for their appointment by the Nomination Committee.

 

Kevin Ingram is an experienced non-executive director having previously been chairman of the Board of Aberdeen UK Tracker Trust Plc. Both Kevin Ingram and Clive Peggram have been independent non-executive directors of the Company since 19 February 2015 and Kevin Ingram has previously served in the role as Chairman of the Audit and Valuation Committee.

 

Mark Katzenellenbogen has been involved in financial services for over 35 years. Since 2007 he has been CEO of Auden Capital LLP, a London based corporate finance advisory firm specialising in the investment and wealth management sector. He began his career with S.G Warburg in credit and banking, prior to working for the bank's mergers and acquisitions department. Since 2005 Mark has been a non-executive director of Oldfield, a long-only value equity manager.

 

Kevin Ingram, Chairman of the Company, said on the appointment of Mark Katzenellenbogen:

"The Directors are delighted that Mark has agreed to accept our invitation to join the Board. We consider that his input as an independent non-executive Director will be extremely valuable as he brings a wealth of experience from his time in financial services to the Board."

 

The following information is disclosed in accordance with Listing Rule 9.16.13.

 

Mark Katzenellenbogen held the following executive directorships of companies at the time of, or within the twelve months preceding a members' voluntary arrangement:

· Jofrethe Ltd, members' voluntary liquidation on 26 July 2015

· Zimbabwe Benefit Foundation, members' voluntary strike-off on 3 January 2017

 

There are no further details or disclosures required under Listing Rule 9.6.13 in respect of Mark Katzenellenbogen.

 

Mark Katzenellenbogen will stand for election as a Director at the Annual General Meeting to be held on 11 June 2019.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Victory Park Capital

Brendan Carroll (Senior Partner and Co-Founder)

Gordon Watson (Partner)

 

 

via MHP (below)

Jefferies International Limited

Tel: +44 20 7029 8000

Gary Gould

Sandra Björck

 

MHP (PR Adviser)

Tel: +44 20 3128 8100

Kelsey Traynor

Tim Rowntree

Email: vpc@mhpc.com

 

ABOUT VPC Specialty Lending Investments PLC:

VPC Specialty Lending Investments PLC invests in opportunities within the specialty lending market primarily through online lending platforms. The Company intends to generate an attractive total return for shareholders consisting of distributable income and capital growth via investments in a diverse portfolio of various platforms, asset classes, geographies (primarily US, UK and Europe) and credit bands.

 

Since 2010, the Company's investment manager, Victory Park Capital, has been actively involved in the specialty lending marketplace and has made more than $6.7 billion of investments and commitments across a number of financial technology platforms, multiple geographies (US, UK and Europe), products (consumer and business) and structures (whole loans and senior credit facilities).

 

Further information on VPC Specialty Lending Investments PLC is available at: http://vpcspecialtylending.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAIAMRTMBBTBRL
Date   Source Headline
2nd May 20244:27 pmRNSNotice of AGM
24th Apr 20247:00 amRNSAnnual Financial Report
22nd Apr 20247:00 amRNSNet Asset Value(s)
17th Apr 20244:30 pmRNSInitial Return of Capital Exchange Ratio
9th Apr 20247:00 amRNSInitial Return of Capital through B Share Scheme
5th Apr 202411:23 amRNSResult of General Meeting
15th Mar 20247:00 amRNSPublication of circular relating to B share scheme
8th Mar 20243:00 pmRNSNet Asset Value(s)
22nd Feb 20248:54 amRNSReplacement - Dividend Declaration
22nd Feb 20247:00 amRNSDividend Declaration
7th Feb 20249:00 amRNSNet Asset Value(s)
17th Jan 20247:00 amRNSNet Asset Value(s)
8th Dec 20237:00 amRNSNet Asset Value(s)
17th Nov 20237:00 amRNSDividend Declaration
13th Nov 20237:00 amRNSNet Asset Value and Monthly Report
5th Oct 20237:00 amRNSNet Asset Value and Monthly Report
29th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSNet Asset Value and Monthly Report
24th Aug 20237:00 amRNSDividend Declaration
8th Aug 20231:21 pmRNSNet Asset Value and Monthly Report
13th Jul 202311:45 amRNSNet Asset Value(s) and Monthly Report
26th Jun 20237:00 amRNSDividend Declaration
23rd Jun 20235:08 pmRNSResult of AGM
12th Jun 20235:31 pmRNSResult of Meeting
7th Jun 20237:00 amRNSNet Asset Value(s)
31st May 20231:26 pmRNSDirectorate Change and Notice of AGM
16th May 20232:58 pmRNSCircular containing a Notice of General Meeting
11th May 202310:07 amRNSNet Asset Value(s)
28th Apr 20237:00 amRNSAnnual Financial Report
11th Apr 20235:33 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSNet Asset Value(s)
7th Mar 20237:00 amRNSNet Asset Value(s)
22nd Feb 20237:00 amRNSDividend Declaration
10th Feb 20237:00 amRNSNet Asset Value(s)
12th Jan 20237:00 amRNSNet Asset Value(s)
22nd Dec 20227:00 amRNSProposed Managed Wind-Down
8th Dec 20227:00 amRNSNet Asset Value(s)
7th Dec 20224:01 pmRNSReceipt of Requisition Notice
30th Nov 20227:00 amRNSDividend Declaration
8th Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 202211:13 amRNSHolding(s) in Company
30th Sep 20227:00 amRNSNet Asset Value(s)
29th Sep 20227:00 amRNSHalf-year Report
31st Aug 20227:00 amRNSNet Asset Value(s)
25th Aug 20227:00 amRNSDividend Declaration
1st Aug 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSNet Asset Value(s)
14th Jun 20227:00 amRNSDividend Declaration
13th Jun 20224:35 pmRNSResult of AGM
8th Jun 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.